Seeing the light: Hyperspectral retinal imaging as a surrogate marker for early stage Alzheimer’s disease

This study demonstrates how hyperspectral retinal imaging combined with AI can detect early signs of Alzheimer’s disease.

Recommended citation: M. Ghesquiere et al. (2025). "Seeing the light: Hyperspectral retinal imaging as a surrogate marker for early stage Alzheimer’s disease." Acta Ophthalmologica 103(S284). doi:10.1111/aos.17369.
Download Paper